These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 12708565

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Role of sodium during formation of edema in children with nephrotic syndrome.
    Gurgoze MK, Gunduz Z, Poyrazoglu MH, Dursun I, Uzum K, Dusunsel R.
    Pediatr Int; 2011 Feb; 53(1):50-6. PubMed ID: 20573038
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Mineralocorticoid effects on Na-K-ATPase in individual nephron segments.
    Garg LC, Knepper MA, Burg MB.
    Am J Physiol; 1981 Jun; 240(6):F536-44. PubMed ID: 6264796
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Modulation of renal sodium-potassium-adenosine triphosphatase by aldosterone. Effect of high physiologic levels on enzyme activity in isolated rat and rabbit tubules.
    Mujais SK, Chekal MA, Jones WJ, Hayslett JP, Katz AI.
    J Clin Invest; 1985 Jul; 76(1):170-6. PubMed ID: 2991336
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Considerations on the sodium retention in nephrotic syndrome.
    Usberti M, Gazzotti RM, Poiesi C, D'Avanzo L, Ghielmi S.
    Am J Nephrol; 1995 Jul; 15(1):38-47. PubMed ID: 7872363
    [Abstract] [Full Text] [Related]

  • 30. Na(+)-K(+)-ATPase activity: role in the impaired sodium excretion of experimental nephrosis in rats.
    Lu SG, Jiang XY, Hu MC, Guo M.
    Chin Med J (Engl); 1994 Jul; 107(7):536-40. PubMed ID: 7956502
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Relation between plasma aldosterone concentration and renal handling of sodium and potassium, in particular in patients with chronic renal failure.
    Hené RJ, Koomans HA, Boer P, Roos JC, Dorhout Mees EJ.
    Nephron; 1984 Jul; 37(2):94-9. PubMed ID: 6374484
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Nephrotic syndrome: vasoconstriction and hypervolemic types indicated by renin-sodium profiling.
    Meltzer JI, Keim HJ, Laragh JH, Sealey JE, Jan KM, Chien S.
    Ann Intern Med; 1979 Nov; 91(5):688-96. PubMed ID: 496101
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Study of the effects of cicletanine on the renin-angiotensin-aldosterone system.
    Bippi H, Guinot P.
    Drugs Exp Clin Res; 1988 Nov; 14(2-3):215-20. PubMed ID: 3046885
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Nephrotic syndrome: new concepts in the pathophysiology of sodium retention.
    Zacchia M, Trepiccione F, Morelli F, Pani A, Capasso G.
    J Nephrol; 2008 Nov; 21(6):836-42. PubMed ID: 19034867
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.